粪便检测在炎症性肠病疾病活动度评估中的应用现状

被引:11
作者
冉雪梅 [1 ]
陈洪 [2 ]
机构
[1] 东南大学医学院
[2] 东南大学附属中大医院消化科
关键词
炎症性肠病; 疾病活动度; 粪便钙卫蛋白; 粪便免疫检测;
D O I
暂无
中图分类号
R574.62 [结肠疾病];
学科分类号
100201 [内科学];
摘要
炎症性肠病是消化道反复发作的一种非特异性炎症性疾病。内镜检查是评估疾病活动度的金标准,但该检查因具有侵入性而限制了其使用。研究证实,粪便检测在评估炎症性肠病疾病活动度方面有良好的应用价值。作者就粪便钙卫蛋白检测、粪便免疫化学检测在评估炎症性肠病疾病活动度中的应用现状作一综述。
引用
收藏
页码:550 / 554
页数:5
相关论文
共 13 条
[1]
非侵入性分子标志物评估临床缓解期炎症性肠病内镜活动度价值研究 [J].
陈金敏 ;
周经委 ;
邓飞鸿 ;
王道蓉 ;
高山 .
中国实用内科杂志, 2016, (11) :971-974
[2]
Ulcerative colitis patients in clinical remission demonstrate correlations between fecal immunochemical test results, mucosal healing, and risk of relapse [J].
Nakarai, Asuka ;
Kato, Jun ;
Hiraoka, Sakiko ;
Takashima, Shiho ;
Takei, Daisuke ;
Inokuchi, Toshihiro ;
Sugihara, Yuusaku ;
Takahara, Masahiro ;
Harada, Keita ;
Okada, Hiroyuki .
WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (21) :5079-5087
[3]
粪便钙卫蛋白检测在炎症性肠病中的应用价值 [J].
叶院宁 ;
汪芳裕 .
医学研究生学报, 2015, 28 (08) :865-869
[4]
Fecal calprotectin for the prediction of small-bowel Crohn's disease by capsule endoscopy: a systematic review and meta-analysis [J].
Kopylov, Uri ;
Yung, Diana E. ;
Engel, Tal ;
Avni, Tomer ;
Battat, Robert ;
Ben-Horin, Shomron ;
Plevris, John N. ;
Eliakim, Rami ;
Koulaouzidis, Anastasios .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 28 (10) :1137-1144
[5]
Fecal Immunochemical Test Versus Fecal Calprotectin for Prediction of Mucosal Healing in Crohn?s Disease.[J].Toshihiro Inokuchi;Jun Kato;Sakiko Hiraoka;Shiho Takashima;Asuka Nakarai;Daisuke Takei;Yuusaku Sugihara;Masahiro Takahara;Seiji Kawano;Keita Harada;Hiroyuki Okada.Inflammatory Bowel Diseases.2016,
[6]
Fecal calprotectin is a clinically relevant biomarker of mucosal healing in patients with quiescent ulcerative colitis [J].
Yamaguchi, Sayaka ;
Takeuchi, Yoshiaki ;
Arai, Katsuhito ;
Fukuda, Katsuyuki ;
Kuroki, Yuichiro ;
Asonuma, Kunio ;
Takahashi, Hiroshi ;
Saruta, Masayuki ;
Yoshida, Hitoshi .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 (01) :93-98
[7]
Correlation Between Concentrations of Fecal Calprotectin and Outcomes of Patients With Ulcerative Colitis in a Phase 2 Trial [J].
Sandborn, William J. ;
Panes, Julian ;
Zhang, Haiying ;
Yu, Dahong ;
Niezychowski, Wojciech ;
Su, Chinyu .
GASTROENTEROLOGY, 2016, 150 (01) :96-102
[8]
Meta-analysis: Fecal Calprotectin for Assessment of Inflammatory Bowel Disease Activity [J].
Lin, Jin-Feng ;
Chen, Jin-Min ;
Zuo, Jun-Hua ;
Yu, Allen ;
Xiao, Zhu-Jun ;
Deng, Fei-Hong ;
Nie, Biao ;
Jiang, Bo .
INFLAMMATORY BOWEL DISEASES, 2014, 20 (08) :1407-1415
[9]
Mucosal healing at 3 months predicts long-term endoscopic remission in anti-TNF-treated luminal Crohn's disease [J].
Af Bjorkesten, Clas-Goran ;
Nieminen, Urpo ;
Sipponen, Taina ;
Turunen, Ulla ;
Arkkila, Perttu ;
Farkkila, Martti .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2013, 48 (05) :543-551
[10]
Lewis Score Correlates More Closely with Fecal Calprotectin Than Capsule Endoscopy Crohn's Disease Activity Index [J].
Koulaouzidis, Anastasios ;
Douglas, Sarah ;
Plevris, John N. .
DIGESTIVE DISEASES AND SCIENCES, 2012, 57 (04) :987-993